At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LIMN Liminatus Pharma LLC
Post-Mkt 07-17 19:03:52 EDT
0.1230
-0.0247
-16.72%
盘后0.1198
-0.0032-2.60%
19:02 EDT
High0.1319Low0.1150Vol25.60M
Open0.1224D1 Closing0.1477Amplitude11.44%
Mkt Cap8.26MTradable Cap3.58MTotal Shares67.16M
T/O3.23MT/O Rate88.05%Tradable Shares29.07M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Liminatus Pharma Discloses Ewon Comfortech Initial Beneficial Ownership of 5.5 Million Shares
Reuters  ·  07-07
Liminatus Pharma Discloses Ewon Comfortech Initial Beneficial Ownership of 5.5 Million Shares
Liminatus Pharma Amends Innocsai Merger Terms to Use Non-voting Convertible Preferred Stock
Reuters  ·  07-06
Liminatus Pharma Amends Innocsai Merger Terms to Use Non-voting Convertible Preferred Stock
NASD Most Active Issues
Dow Jones  ·  07-03
NASD Most Active Issues
Top Premarket Gainers
MT Newswires Live  ·  07-02
Top Premarket Gainers
Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Session (UPDATED)
Benzinga_recent_news  ·  07-02
Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Session (UPDATED)
Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday
MT Newswires Live  ·  07-01
Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday
Liminatus Pharma amends, restates merger agreement with InnocsAI
TIPRANKS  ·  07-01
Liminatus Pharma amends, restates merger agreement with InnocsAI
Liminatus Pharma Amends Innocsai Merger Terms, Targets July 2 Close
Reuters  ·  07-01
Liminatus Pharma Amends Innocsai Merger Terms, Targets July 2 Close
Liminatus Pharma - Innocsai Equity Holders to Receive up to 19.99% of Liminatus Common Stock
THOMSON REUTERS  ·  07-01
Liminatus Pharma - Innocsai Equity Holders to Receive up to 19.99% of Liminatus Common Stock
Liminatus Pharma Amends Definitive Merger Agreement with Innocsai to Expand Oncology Cell Therapy Pipeline
THOMSON REUTERS  ·  07-01
Liminatus Pharma Amends Definitive Merger Agreement with Innocsai to Expand Oncology Cell Therapy Pipeline
Liminatus Pharma - Innocsai Merger Valued at $320 Mln with $0.2 Per Share Issue Price
THOMSON REUTERS  ·  07-01
Liminatus Pharma - Innocsai Merger Valued at $320 Mln with $0.2 Per Share Issue Price
Liminatus Pharma Announces Annual Shareholder Meeting
Reuters  ·  06-30
Liminatus Pharma Announces Annual Shareholder Meeting
Liminatus Pharma issues new warrants for 20,688,000 shares in inducement deal
Reuters  ·  06-03
Liminatus Pharma issues new warrants for 20,688,000 shares in inducement deal
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
THOMSON REUTERS  ·  06-03
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
Liminatus Pharma appeals Nasdaq delisting notice after missing $50 million market value rule
Reuters  ·  05-28
Liminatus Pharma appeals Nasdaq delisting notice after missing $50 million market value rule
Liminatus Pharma receives Nasdaq delisting notice
TIPRANKS  ·  05-22
Liminatus Pharma receives Nasdaq delisting notice
Liminatus Pharma appeals Nasdaq delisting notice, trading suspension set May 29
Reuters  ·  05-22
Liminatus Pharma appeals Nasdaq delisting notice, trading suspension set May 29
Liminatus Pharma Announces Nasdaq Delisting Notification
THOMSON REUTERS  ·  05-22
Liminatus Pharma Announces Nasdaq Delisting Notification
NASD Most Active Issues
Dow Jones  ·  05-22
NASD Most Active Issues
Liminatus Pharma agrees to merge with InnocsAI in $320 million stock deal
Reuters  ·  05-21
Liminatus Pharma agrees to merge with InnocsAI in $320 million stock deal

Introduction

Company Name.
Liminatus Pharma LLC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Iris Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Tribe Capital Growth Corp I and changed its name to Iris Acquisition Corp in July 2022. The company was incorporated in 2020 and is based in George Town, Cayman Islands. Iris Acquisition Corp is a subsidiary of Iris Acquisition Holdings LLC.
Issue price:
--